Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Lifestyle Interventions for Weight Management in People with Serious Mental Illness : A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects. / Speyer, Helene; Jakobsen, Ane Storch; Westergaard, Casper; Nørgaard, Hans Christian Brix; Pisinger, Charlotta; Krogh, Jesper; Hjorthøj, Carsten; Nordentoft, Merete; Gluud, Christian; Correll, Christoph U.; Jørgensen, Kirstine Bro.
I: Psychotherapy and Psychosomatics, Bind 88, Nr. 6, 2019, s. 350-362.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Lifestyle Interventions for Weight Management in People with Serious Mental Illness
T2 - A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects
AU - Speyer, Helene
AU - Jakobsen, Ane Storch
AU - Westergaard, Casper
AU - Nørgaard, Hans Christian Brix
AU - Pisinger, Charlotta
AU - Krogh, Jesper
AU - Hjorthøj, Carsten
AU - Nordentoft, Merete
AU - Gluud, Christian
AU - Correll, Christoph U.
AU - Jørgensen, Kirstine Bro
PY - 2019
Y1 - 2019
N2 - Background: Serious mental illness (SMI) reduces life expectancy, primarily due to somatic comorbidity linked to obesity. Meta-analyses have found beneficial effects of lifestyle interventions in people with SMI and recommended their implementation to manage obesity. Objective: The objective of this systematic review was to assess the benefits and harms of individualized lifestyle interventions for weight in people diagnosed with SMI and to explore potential mediators and moderators of the effect. Methods: The protocol was registered at PROSPERO (CRD42016049093). Randomized clinical trials (RCTs) assessing the effect of individualized lifestyle interventions on weight management in people with SMI were included. Primary outcomes were differences in endpoint body mass index (BMI) and the proportion achieving clinically relevant weight loss (≥5%). Secondary outcomes included quality of life, cardiometabolic risk factors, and adverse effects. Results: We included 41 RCTs (n = 4,267). All trials were at high risk of bias according to the Cochrane Handbook for Systematic Reviews of Interventions. The experimental interventions reduced the mean difference in BMI by -0.63 kg/m (95% confidence interval [CI] = -1.02 to -0.23; p = 0.002; I = 70.7%) compared to the control groups. At postintervention follow-up (17 RCTs), the effect size remained similar but was no longer significant (BMI = -0.63 kg/m 95% CI = -1.30 to 0.04; p = 0.07; I = 48.8%). The risk ratio for losing ≥5% of baseline weight was 1.51 (95% CI = 1.07-2.13; p = 0.02) compared to the control groups. GRADE showed very low or low quality of evidence. Conclusion: There is a statistically significant, but clinically insignificant, mean effect of individualized lifestyle interventions for weight reduction in people with SMI.
AB - Background: Serious mental illness (SMI) reduces life expectancy, primarily due to somatic comorbidity linked to obesity. Meta-analyses have found beneficial effects of lifestyle interventions in people with SMI and recommended their implementation to manage obesity. Objective: The objective of this systematic review was to assess the benefits and harms of individualized lifestyle interventions for weight in people diagnosed with SMI and to explore potential mediators and moderators of the effect. Methods: The protocol was registered at PROSPERO (CRD42016049093). Randomized clinical trials (RCTs) assessing the effect of individualized lifestyle interventions on weight management in people with SMI were included. Primary outcomes were differences in endpoint body mass index (BMI) and the proportion achieving clinically relevant weight loss (≥5%). Secondary outcomes included quality of life, cardiometabolic risk factors, and adverse effects. Results: We included 41 RCTs (n = 4,267). All trials were at high risk of bias according to the Cochrane Handbook for Systematic Reviews of Interventions. The experimental interventions reduced the mean difference in BMI by -0.63 kg/m (95% confidence interval [CI] = -1.02 to -0.23; p = 0.002; I = 70.7%) compared to the control groups. At postintervention follow-up (17 RCTs), the effect size remained similar but was no longer significant (BMI = -0.63 kg/m 95% CI = -1.30 to 0.04; p = 0.07; I = 48.8%). The risk ratio for losing ≥5% of baseline weight was 1.51 (95% CI = 1.07-2.13; p = 0.02) compared to the control groups. GRADE showed very low or low quality of evidence. Conclusion: There is a statistically significant, but clinically insignificant, mean effect of individualized lifestyle interventions for weight reduction in people with SMI.
KW - Adverse effect
KW - Antipsychotics
KW - Lifestyle intervention
KW - Metabolic risk factors
KW - Obesity
KW - Quality of life
KW - Serious mental illness
KW - Weight loss
U2 - 10.1159/000502293
DO - 10.1159/000502293
M3 - Review
C2 - 31522170
AN - SCOPUS:85072542610
VL - 88
SP - 350
EP - 362
JO - Psychotherapy and Psychosomatics
JF - Psychotherapy and Psychosomatics
SN - 0033-3190
IS - 6
ER -
ID: 236324170